After introducing Gemini 2.0 Flash late last year, Google is finally ready for the powerful AI model to drop its "experimental" label.

Google's Threat Intelligence Group (GTIG) has uncovered evidence of government-backed threat actor use of Gemini AI.

announced today that it has started its PRIME (PReconditioning IMmunostimulatory Evaluation) Phase 1b clinical study of escalating doses of intravenously administered Gemini in patients with Stage ...

Beyond just being faster than the 1.5 edition, Flash 2.0 promised greatly improved support for handling media input, letting you prime Gemini with pictures and video. Specifically, Google points ...

Data from the PRIME clinical study will support future development in both the GEM-CKD and GEM-AKI programs. Gemini is an intravenously administrated, proprietary formulation of phosphorylated ...